Latest Breaking News On - Karl pringle - Page 2 : comparemela.com

Skip to main content Currently Reading GenXys HealthCare Systems announces completion of oversubscribed seed round financing to enable continued market penetration with acclaimed precision prescribing software PRWeb FacebookTwitterEmail VANCOUVER, British Columbia (PRWEB) March 01, 2021 GenXys, a health tech company focused on pharmacogenetic enhanced prescribing automation software, is pleased to announce that it has closed an oversubscribed seed round at $3 million. Led by Green Shield Canada (GSC), with key investors including TELUS Ventures, Esplanade Ventures, Nimbus Synergies, and the Business Development Bank of Canada (BDC Capital). GenXys provides evidence-based medication decision support tools with embedded pharmacogenetics to enable precision prescribing seamlessly at the point of care. Building on recent successes in the Canadian and US markets, the company plans to accelerate their expansion in the North American market meeting the needs of genetic lab companies,

United-states
Canada
Vancouver
British-columbia
America
American
Canadian
Karl-pringle
Business-development-bank
Telus
Xys-healthcare-systems
Green-shield-canada